FindTrial
Sign In

Quality of Life and Pain With Infiltration or Suprascapular Nerve Block in Glenohumeral Arthirtis

Health Related Quality of Life and Pain Managment Using Infiltration or Suprascapular Nerve Block Ultrasound Guided in Patients With Glenohumeral Arthirtis

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03794505
Enrollment
40
Registered
2019-01-07
Start date
2018-04-01
Completion date
2018-08-30
Last updated
2019-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Arthritis

Brief summary

Efficacy in pain and health related quality of life of suprascapular nerve block ultrasound guided and glenohumeral infiltration in glenohumeral arthritis

Detailed description

To describe the efficacy in pain management and health related quality of life of suprascapular nerve block ultrasound guided and glenohumeral infiltration in patients with glenohumeral arthritis

Interventions

DRUGMethylprednisolone Acetate

depo-medrol 40 mg

DRUGLidocaine 2% Injectable Solution

2ml of 2% lidocaine

DRUGRopivacaine HCl Inj 7.5 MG/ML

25 mg

Sponsors

Instituto Mexicano del Seguro Social
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* IMSS affiliated * Glenohumeral arthritis diagnosed

Exclusion criteria

* Previusly treatment for the same disease * No follow up * Dead

Design outcomes

Primary

MeasureTime frameDescription
Pain beforeVAS before interventionvisual analogue scale
Pain 2 months afterVAS 2 months afterVisual analogue scale 2 months after procedure
Pain 6 months afterVAS 6 months afterVisual analogue scale 6 months after procedure

Secondary

MeasureTime frameDescription
Quality of life before procedureSF12v2 before procedureSF12v2 Health related quality of life before procedure
Quality of life 2 months after procedureSF12v2 2 months afterSF12v2 Health related quality of life 2 months after
Quality of life 6 months after procedureSF12v2 6 months afterSF12v2 Health related quality of life 6 months after

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026